What is the most recent earnings date for NMTC stock?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) last reported earnings on 2/17/2026.
NEUROONE MEDICAL TECHNOLOGIE (NMTC) Earnings History & Surprises
NASDAQ:NMTC • US64130M2098
Current stock price
0.795 USD
-0.01 (-0.87%)
Last:
NMTC Earnings overview
Past quarterly earnings results for NEUROONE MEDICAL TECHNOLOGIE (NMTC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q2 / 2026
- EPS Estimate
- -$0.04
- Revenue Estimate
- 2.628M
Last Reported
Most Recent- Release Date
- Feb 17, 2026
- Period
- Q1 / 2026
- EPS Reported
- -$0.03
- EPS Surprise
- 26.47%
- Revenue Surprise
- 5.88%
Beat Rate
Last 8 Quarters 19%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | -0.03 | -0.04 | 26.47% | -150.00% | 2.893M | 2.732M | 5.88% | -11.54% |
| Q4 2025 | -0.04 | -0.04 | 1.96% | 63.64% | 2.741M | 2.519M | 8.81% | 915.16% |
| Q3 2025 | -0.03 | -0.05 | 41.18% | 70.59% | 1.696M | 1.856M | -8.62% | 105.38% |
| Q2 2025 | -0.07 | -0.09 | 23.75% | 36.36% | 1.39M | 2.448M | -43.22% | 0.72% |
| Q1 2025 | 0.06 | -0.10 | 158.82% | 142.86% | 3.27M | 2.142M | 52.66% | 234.48% |
| Q4 2024 | -0.11 | -0.08 | -34.80% | 15.38% | 270K | 2.346M | -88.49% | -65.50% |
| Q3 2024 | -0.10 | - | 49.00% | 825.8K | 2.04M | -59.52% | 31.08% | |
| Q2 2024 | -0.11 | -0.10 | -7.84% | 47.62% | 1.38M | 1.734M | -20.42% | 196.14% |
| Q1 2024 | -0.14 | -0.14 | 1.96% | -27.27% | 977.65K | 869.04K | 12.50% | -37.73% |
| Q4 2023 | -0.13 | -0.18 | 27.17% | -44.44% | 782.52K | 816K | -4.10% | -61.07% |
| Q3 2023 | -0.20 | -0.21 | 4.35% | -17.65% | 630K | 357K | 76.47% | 2,000.00% |
| Q2 2023 | -0.21 | -0.21 | -0.43% | -10.53% | 466K | 255K | 82.75% | 1,065.00% |
| Q1 2023 | -0.11 | -0.11 | 1.96% | 38.89% | 1.57M | 1.938M | -18.99% | 3,825.00% |
| Q4 2022 | -0.09 | -0.11 | 19.79% | 59.09% | 2.01M | 3.672M | -45.26% | 3,920.00% |
| Q3 2022 | -0.17 | -0.23 | 25.93% | 32.00% | 30K | - | -50.00% | |
| Q2 2022 | -0.19 | -0.20 | 6.86% | - | 40K | - | - | |
| Q1 2022 | -0.18 | -0.19 | 4.61% | - | 40K | - | -55.56% | |
| Q4 2021 | -0.22 | -0.22 | 1.96% | - | 50K | 102K | -50.98% | -97.41% |
| Q3 2021 | -0.25 | - | - | 60K | - | - | ||
| Q2 2021 | - | - | 40K | - | - | |||
| Q1 2021 | - | - | 90K | - | - | |||
| Q4 2020 | - | - | 1.93M | - | - | |||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
23.34%
Max EPS beat (4)
41.18%
Min EPS beat (4)
1.96%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-9.29%
Max Revenue beat (4)
8.81%
Min Revenue beat (4)
-43.22%
Analysis
In the last 4 quarters, NMTC has consistently beaten EPS estimates in all releases
NMTC has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, NMTC has beaten the EPS estimates by 23.3% on average.
In the last 4 quarters, NMTC reported -9.3% below the revenue estimates on average.
Related analysis
NEUROONE MEDICAL TECHNOLOGIE / NMTC Earnings FAQ
Can you provide information on whether NEUROONE MEDICAL TECHNOLOGIE beat earnings estimates in the last quarter?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does NEUROONE MEDICAL TECHNOLOGIE (NMTC) beat earnings estimates?
In the last 4 quarters, NEUROONE MEDICAL TECHNOLOGIE (NMTC) has beaten EPS estimates in 4 out of 4 releases.